Quarter Ended Mar 31, 2024
Net sales were up 2% to $111.0 million compared to $108.6 million (up 4% in constant currency).
GAAP net income attributable to common shareholders up significantly to $2.3 million, or $0.12 per diluted common share, compared to $0.9 million, or $0.04 per diluted common share.
Adjusted EBITDA up slightly to $9.2 million compared to $9.1 million.
For complete information regarding our financials, see our periodic filings.